Back to search
FDAFDA · Food and drugs·Recall number D-1513-2014

buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 500-count bottle, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA, LLC, 20 Waterview Blvd, Parsippany, NJ 07054 USA, NDC 64679-101-07.

Published August 13, 2014 · Recall initiated: July 14, 2014

Summary

FDA records drug Class III recall D-1513-2014, published August 13, 2014 and initiated July 14, 2014. Recalling firm: Wockhardt Usa Inc.; Status: Terminated; Reported quantity: 840 bottles; Lot: Lot #: DN10635, Exp 01/15; DM13402, DN10247, Exp 11/14; and DM13449, Exp 07/14. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Products: Out of specification levels of the impurity m-chlorobenzoic acid were observed.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Wockhardt Usa Inc.
Distributor
Nationwide
Lot
Lot #: DN10635, Exp 01/15; DM13402, DN10247, Exp 11/14; and DM13449, Exp 07/14
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 500-count bottle, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA, LLC, 20 Waterview Blvd, Parsippany, NJ 07054 USA, NDC 64679-101-07. recalled?

Yes. FDA published recall D-1513-2014 on August 13, 2014. Reported hazard: Failed Impurities/Degradation Products: Out of specification levels of the impurity m-chlorobenzoic acid were observed.

What should I do if I have this product?

Voluntary: Firm initiated · Letter